• N/A
    Market Cap
  • -10.75%
    1-Year Change
  • Household & Personal Products
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: 48
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

Laundry Detergents Market to Reach USD 131.49 Billion by 2035 Amid Rising Demand for Liquid Pods and Premium Fabric Care Solutions | Report by SNS Insider

The global laundry detergents market is projected to grow from USD 79.2 billion in 2025 to USD 131.49 billion by 2035, with a CAGR of 5.20%. Growth is driven by increasing demand for liquid detergents and single-dose pods, premiumization of fabric care products, and expansion in e-commerce distribution. The U.S. market is expected to reach USD 23.24 billion by 2035, while Europe hits USD 33.54 billion, with North America as the fastest-growing region.

05/30/2026, 9:30 AMGlobeNewswire

Infant Nutrition Market Projected to Reach US$ 162.08 Billion by 2035, Supported by Regulatory Developments and Product Innovation Says Astute Analytica

The global infant nutrition market is shifting from volume-based to value-driven growth, projected to reach $162.08 billion by 2035 at a 10.26% CAGR. Despite declining birth rates, premium formulations and specialized nutrition products are driving growth. Major players are investing heavily in domestic manufacturing, regulatory compliance, and product innovation, while safety recalls and consolidation reshape the competitive landscape.

02/02/2026, 10:30 AMGlobeNewswire

United States Air Fresheners Market Report 2025: Consumer Trends & Forecasts to 2033

The US air fresheners market is projected to grow from $2.71 billion in 2024 to $3.86 billion by 2033, driven by consumer preferences for home and car fragrances, with a 4.02% CAGR. Market growth is fueled by increasing demand for personalized, hygienic fragrance solutions across residential, automotive, and commercial sectors.

11/26/2025, 4:54 AMGlobeNewswire

Global Contraceptive Devices Market is Set to Accelerate at a CAGR of ~6% by 2032, as Demand for Advanced Birth Control Solutions Rises | DelveInsight

The global contraceptive devices market is projected to grow from $20 billion in 2024 to $33 billion by 2032, driven by increased awareness, technological innovations, and changing demographic trends.

11/17/2025, 1:00 PMGlobeNewswire

Mosquito Repellent Market Report 2025-2033 | Citronella Dominate as Consumers Move to Natural Ingredients

The global mosquito repellent market is projected to grow from $5.3 billion in 2024 to $8.1 billion by 2033, driven by increasing awareness of mosquito-borne diseases, travel expansion, and consumer preference for natural ingredients like citronella.

08/19/2025, 6:56 AMGlobeNewswire

Reckitt Benckiser Group PLC Investors: Please contact the Portnoy Law Firm to recover your losses. August 4, 2025 Deadline to file Lead Plaintiff Motion

Reckitt Benckiser faces a class action lawsuit alleging misleading statements about health risks associated with its Enfamil infant formula, particularly for preterm infants. Two jury verdicts totaling $555 million have highlighted potential negligence in warning about Necrotizing Enterocolitis (NEC) risks.

08/04/2025, 6:00 PMGlobeNewswire

מחר המועד האחרון לתביעה נגד RBGLY: רוזן, משרד עורכי דין מוביל, מעודד את משקיעי Reckitt Benckiser Group PLC להשיג ייעוץ לפני המועד האחרון החשוב של 4 באוגוסט בתביעה ייצוגית בניירות ערך – RBGLY

Rosen Law Firm reminds investors of an important August 4, 2025 deadline for a securities class action lawsuit against Reckitt Benckiser Group PLC, alleging the company failed to disclose risks related to infant formula and potential legal liabilities.

08/03/2025, 11:03 AMGlobeNewswire

RBGLY DEADLINE TOMORROW: ROSEN, A TOP RANKED LAW FIRM, Encourages Reckitt Benckiser Group PLC Investors to Secure Counsel Before Important August 4 Deadline in Securities Class Action – RBGLY

Rosen Law Firm is alerting Reckitt Benckiser Group PLC investors about a securities class action lawsuit regarding potential misleading statements about risks associated with their Enfamil infant formula.

08/03/2025, 11:03 AMGlobeNewswire

RECKITT (RBGLY) URGENT DEADLINE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Reckitt Benckiser Group plc and Encourages Investors to Contact the Firm

A class action lawsuit has been filed against Reckitt Benckiser Group for allegedly misleading investors about health risks associated with their infant formula, with over 500 products liability lawsuits claiming increased necrotizing enterocolitis risk for premature infants.

08/02/2025, 10:21 AMGlobeNewswire

Shareholders of Reckitt Benckiser Group plc Should Contact The Gross Law Firm Before August 4, 2025 to Discuss Your Rights - RBGLY

The Gross Law Firm is notifying shareholders of Reckitt Benckiser Group plc about a potential class action lawsuit regarding allegations of misleading statements about health risks associated with their Enfamil infant formula.

07/31/2025, 8:45 AMBenzinga

RBGLY INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Reckitt Benckiser Group PLC Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

A class action lawsuit has been filed against Reckitt Benckiser Group PLC alleging false statements about health risks associated with their Enfamil infant formula, specifically concerning necrotizing enterocolitis (NEC) in preterm infants.

07/30/2025, 4:00 PMGlobeNewswire

RECKITT BENCKISER SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Reckitt Benckiser Group PLC - RBGLY

Law firm alerts investors about potential securities class action lawsuit against Reckitt Benckiser for allegedly failing to disclose material information about health risks associated with Enfamil infant formula.

07/29/2025, 10:30 PMGlobeNewswire

Reckitt Benckiser Group plc Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before August 4, 2025 to Discuss Your Rights - RBGLY

Reckitt Benckiser Group plc faces a class action lawsuit alleging securities fraud related to potential health risks associated with their Enfamil infant formula, with investors having until August 4, 2025 to participate in potential legal recovery.

07/29/2025, 8:45 AMBenzinga

RECKITT (RBGLY) DEADLINE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Reckitt Benckiser Group plc and Encourages Investors to Contact the Firm

A class action lawsuit has been filed against Reckitt Benckiser Group for allegedly misleading investors about health risks associated with their infant formula, with over 500 products liability lawsuits claiming increased necrotizing enterocolitis risk for premature infants.

07/28/2025, 7:09 PMGlobeNewswire

Reckitt Benckiser Group PLC Investors: Please contact the Portnoy Law Firm to recover your losses; August 4, 2025 Deadline to file Lead Plaintiff Motion

Reckitt Benckiser faces a class action lawsuit alleging failure to warn consumers about health risks associated with Enfamil infant formula, potentially causing Necrotizing Enterocolitis (NEC) in preterm infants.

07/28/2025, 4:44 PMGlobeNewswire

Peers

Statistics

More
Day Range
$12.33
$12.42
$12.41
1-Year Range
$12.13
$16.76
$12.41
Latest Close$12.41
Change
+$0.08 (+0.64%)
Volume1,016,578

Information as of 06/23/2026

Company Profile

RECKITT BENCKISER GROUP PLC
https://www.reckitt.com
N/A
Market Cap
N/A
Net Income
Sector: Consumer Defensive
Industry: Household & Personal Products
Turner House, Slough, United Kingdom, SL1 3UH
44 17 5321 7800

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom and internationally. The company offers germ protection under Dettol name; intimate wellness under Durex and KY brand names; over the counter under the Biofreeze, Gaviscon, Mucinex, Nurofen, Delsym, Cepacol, and Strepsils names. It also provides personal care products under Clearasil and Veet brand names; vitamins, minerals, and supplements under MegaRed, Airborne, Digestive-Advantage, Movefree, and neuriva names; stain removal under Vanish brand name; and disinfectant products under the Finish, Harpic, and Lysol brands. In addition, the company offers nutritious complementary foods and milk formulas for infant and young children under the Enfamil and Nutramigen brands. Reckitt Benckiser Group plc was founded in 1819 and is headquartered in Slough, the United Kingdom.

Key Executives

  • Kristoffer Loe Licht
  • Shannon Sue Eisenhardt
  • Jerome Lemaire
  • Susan Sholtis
  • Sheila Redzepi

Current Ownership Distribution

  • Other2.9B (92.16%)
  • Mutual Funds191.2M (6.02%)
  • Institutions57.6M (1.81%)
  • Insiders0 (0.00%)